No description available.

Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus associated disease (PCVAD), an economically important swine disease that causes wasting in pigs 5-18 weeks of age. There exist two different types of porcine circoviruses: porcine circovirus type 1 (PCV1) was discovered as a contaminant of porcine kidney (PK-15) cells and was determined to be nonpathogenic in swine; whereas porcine circovirus type 2 (PCV2) is pathogenic. A recently released vaccine for PCVAD was generated by inserting the gene encoding the immunogenic capsid protein of PCV2 into the genetic backbone of the non-pathogenic PCV1. This chimeric PCV vaccine, called PCV1-2, was shown to induce protective immunity against PCV2 infection in pigs. The vaccine is currently on the market in a killed form. In order to develop a live version of the vaccine, the genetic stability of the chimeric PCV1-2 vaccine virus was investigated by in vitro and in vivo passaging of the vaccine virus. In vitro passaging of the PCV1-2 vaccine virus was done in a porcine kidney PK-15 cell line. Cells were infected with the PCV1-2 vaccine virus and then serially passaged 11 times. The passaged vaccine viruses recovered from passages 5 and 11 were sequenced, and the sequences were compared to that of the original PCV1-2 vaccine virus. The in vitro serial passage result showed that no mutation occurred during the 11 in vitro passages. The in vivo passaging was done using specific-pathogen-free (SPF) pigs. In in vivo "passage 1", nine piglets were divided into 3 groups of 3 each: group 1 each inoculated with 200ug of PCV1-2 plasmid, group 2 each with 1Ã 103 TCID50 live PCV1-2 vaccine virus, and group 3 each with 3ml phosphate buffered saline (PBS) buffer as a control. One pig from each group was necropsied at 14, 21, and 28 days post-inoculation (DPI), respectively. A panel of tissue samples including lymph nodes and thymus were collected from each pig. Tissue homogenates from DPI 28 that were positive by PCR for PCV1-2 DNA were used to inoculate new piglets in the in vivo passage 2 experiment. Viruses recovered from passage 2 pigs were subsequently used for inoculation in the in vivo passage 3 experiment. The PCV1-2 vaccine virus DNA from pigs in each passage was amplified and sequenced. The results of the in vivo serial passage experiment showed that, after 3 passages of the PCV1-2 vaccine virus in pigs, there were no new mutations in the viruses recovered from pigs. The PCV1-2 vaccine contained an introduced marker mutation at amino acid position number 79, which is in the capsid region. During the in vivo passaging of the vaccine virus in pigs, this marker mutation quickly reverted back to its original nucleotide. This marker back mutation occurred between DPI 21 and DPI 28 of passage 1 in the PCV1-2 live vaccine virus group, and between DPI 28 of passage 1 and DPI 14 of passage 2 in the PCV1-2 vaccine plasmid group, and remained stable throughout the reminder of the in vivo study. Based upon the results from this study, we conclude that the PCV1-2 chimeric vaccine virus is genetically stable in vitro and in pigs, and thus should serve as a good candidate for a live vaccine against PCV2. / Master of Science

The non-pathogenic porcine circovirus type 1 (PCV1) was originally isolated as a persistent contaminant of the porcine kidney cell line PK-15. Whereas, porcine circovirus type 2 (PCV2) causes postweaning multisystemic wasting syndrome (PMWS) in pigs, which is devastating to the swine industry. My objectives were to determine the effect of maternally derived antibodies on PCV2 infection, assess the role of 2 amino acid substitutions in the PCV2 capsid protein in PCV2 attenuation, evaluate the effect of Rep gene exchange between PCV1 and PCV2 on growth characteristics of a chimeric PCV2, and evaluate the role of open reading frame (ORF) 3 of PCV2 in virus replication and pathogenesis in pigs. Under field conditions, PCV2 infection is widespread and most breeding pigs are seropositive. Assessment of the role of PCV2 maternal antibodies in preventing PCV2 infection in piglets provided evidence that higher levels of maternal antibody provide more protection to piglets. Two amino acid substitutions in the PCV2 capsid protein that enhanced virus replication in vitro and attenuated the virus in vivo were evaluated for their pathogenicity in pigs. The results indicated that P110A and R191S are collectively responsible for virus attenuation. PCV1 replicates better in PK-15 cells and grows at least 1-log titer higher than PCV2. A chimeric PCV with the rep gene of PCV1 replacing that of PCV2 in the genomic backbone of PCV2 replicated more rapidly than PCV1 and PCV2, and more efficiently than PCV2, although to a titer similar to PCV1. The ORF3 of PCV2 is believed to encode a protein involved in apoptosis. The ORF3 start codon was mutated from ATG to GTG and the resulting mutant muPCV2 was infectious in vitro and in pigs; therefore ORF3 is dispensable for virus replication. The pathogenicity of muPCV2 was compared with PCV2 in vivo. Delayed viremia and seroconversion, decreased viral loads, lower level of IgG antibodies, and lower amounts of PCV2 antigen in mesenteric lymph nodes suggested attenuation of muPCV2. However, there was no significant difference in histological or gross lesions in tissues between PCV2- and muPCV2-inoculated groups. The role of ORF3 in attenuation needs to be further elucidated. / Ph. D.

A Síndrome Multissistêmica do Definhamento do Suíno (SMDS) é uma doença emergente e mundialmente distribuída, que tem trazido sérios prejuízos econômicos para a indústria suinícola. O Circovírus Suíno tipo 2 (PCV2), agente causal da doença, provoca lesões principalmente nos tecidos linfóides, e sugere-se que produza imunossupressão, predispondo o hospedeiro a infecções virais, bacterianas e fúngicas secundárias. Neste trabalho, é descrito um estudo da prevalência e bacteriologia das otites purulentas em suínos apresentando a SMDS, bem como em animais de baixo desenvolvimento e de crescimento normal. No total, foram examinados 385 suínos com idades entre 60 e 130 dias. De 242 animais com a SMDS, 57 (23,5%) apresentaram lesões purulentas no ouvido médio. Dentre 119 animais de baixo desenvolvimento, apenas 1 (0,7%) apresentou a lesão. Não foram detectadas lesões macroscópicas no ouvido médio dos 24 animais com crescimento normal (controles). Os agentes isolados com maior freqüência das lesões foram Arcanobacterium pyogenes, Streptococcus α– hemolíticos e Pasteurella multocida, encontrados em, respectivamente, 37 (43%), 32 (37,2%) e 24 (27,9%) dos 86 ouvidos submetidos à bacteriologia. A alta prevalência de lesões purulentas no ouvido médio de animais com a SMDS sugere que a infecção pelo PCV2 pode tornar o suíno mais suscetível às otites bacterianas. Por outro lado, a prevalência reduzida das lesões em suínos de baixo desenvolvimento sugere que a otite não representa uma causa importante de mau desempenho em suínos nas fases de crescimento e terminação. O isolamento do A. pyogenes, de Streptococcus α- hemolíticos e da P. multocida na maioria das lesões está de acordo com relatos anteriores, confirmando a importância desses organismos como agentes causais da otite média em suínos. / Postweaning Multisystemic Wasting Syndrome (PMWS) is an emerging disease disseminated globally that causes severe losses to the pig industry. Porcine circovirus type 2 (PCV2) is the causal agent of the disease and causes lesions mainly in lymphoid tissue and it is suggested that it can cause immunosuppression, predisposing the host to viral, bacterial and mycotic infections. In the present work we describe a study on prevalence and bacteriology of purulent otitis in pigs with PMWS, as well as in pigs with attrition and pigs with normal growth. A total amount of 385 animals were examined, with ages ranging from 60 to 130 days. Among 242 pigs with PMWS, 57 (23,5%) showed purulent lesions in the middle ear. Among 119 pigs with attrition, only 1 (0,7%) presented the lesion. In 24 control pigs, middle ear lesions were not detected. The agents most frequently isolated from the lesions were Arcanobacterium pyogenes, α–hemolytic Streptococci and Pasteurella multocida, found respectively in 36 (43%), 32 (37,2%) and 24 (27,9%) of 86 ears bacteriologically examined. The high prevalence of purulent lesions found in middle ear of PMWS affected pigs suggests that PCV2 infection can increase susceptibility of swine to bacterial otitis. On the other hand, the small prevalence of lesions in piglets with attrition suggests that otitis does not represent a significant cause for depressed growth in pigs from growing and finishing ages. The isolation of A. pyogenes, α-hemolytic Streptococci and P. multocida from most lesions agrees with previous reports, confirming the importance of these organisms as causal agents in the etiology of otitis media in pigs.

A Síndrome Multissistêmica do Definhamento do Suíno (SMDS) é uma doença emergente e mundialmente distribuída, que tem trazido sérios prejuízos econômicos para a indústria suinícola. O Circovírus Suíno tipo 2 (PCV2), agente causal da doença, provoca lesões principalmente nos tecidos linfóides, e sugere-se que produza imunossupressão, predispondo o hospedeiro a infecções virais, bacterianas e fúngicas secundárias. Neste trabalho, é descrito um estudo da prevalência e bacteriologia das otites purulentas em suínos apresentando a SMDS, bem como em animais de baixo desenvolvimento e de crescimento normal. No total, foram examinados 385 suínos com idades entre 60 e 130 dias. De 242 animais com a SMDS, 57 (23,5%) apresentaram lesões purulentas no ouvido médio. Dentre 119 animais de baixo desenvolvimento, apenas 1 (0,7%) apresentou a lesão. Não foram detectadas lesões macroscópicas no ouvido médio dos 24 animais com crescimento normal (controles). Os agentes isolados com maior freqüência das lesões foram Arcanobacterium pyogenes, Streptococcus α– hemolíticos e Pasteurella multocida, encontrados em, respectivamente, 37 (43%), 32 (37,2%) e 24 (27,9%) dos 86 ouvidos submetidos à bacteriologia. A alta prevalência de lesões purulentas no ouvido médio de animais com a SMDS sugere que a infecção pelo PCV2 pode tornar o suíno mais suscetível às otites bacterianas. Por outro lado, a prevalência reduzida das lesões em suínos de baixo desenvolvimento sugere que a otite não representa uma causa importante de mau desempenho em suínos nas fases de crescimento e terminação. O isolamento do A. pyogenes, de Streptococcus α- hemolíticos e da P. multocida na maioria das lesões está de acordo com relatos anteriores, confirmando a importância desses organismos como agentes causais da otite média em suínos. / Postweaning Multisystemic Wasting Syndrome (PMWS) is an emerging disease disseminated globally that causes severe losses to the pig industry. Porcine circovirus type 2 (PCV2) is the causal agent of the disease and causes lesions mainly in lymphoid tissue and it is suggested that it can cause immunosuppression, predisposing the host to viral, bacterial and mycotic infections. In the present work we describe a study on prevalence and bacteriology of purulent otitis in pigs with PMWS, as well as in pigs with attrition and pigs with normal growth. A total amount of 385 animals were examined, with ages ranging from 60 to 130 days. Among 242 pigs with PMWS, 57 (23,5%) showed purulent lesions in the middle ear. Among 119 pigs with attrition, only 1 (0,7%) presented the lesion. In 24 control pigs, middle ear lesions were not detected. The agents most frequently isolated from the lesions were Arcanobacterium pyogenes, α–hemolytic Streptococci and Pasteurella multocida, found respectively in 36 (43%), 32 (37,2%) and 24 (27,9%) of 86 ears bacteriologically examined. The high prevalence of purulent lesions found in middle ear of PMWS affected pigs suggests that PCV2 infection can increase susceptibility of swine to bacterial otitis. On the other hand, the small prevalence of lesions in piglets with attrition suggests that otitis does not represent a significant cause for depressed growth in pigs from growing and finishing ages. The isolation of A. pyogenes, α-hemolytic Streptococci and P. multocida from most lesions agrees with previous reports, confirming the importance of these organisms as causal agents in the etiology of otitis media in pigs.

A Síndrome Multissistêmica do Definhamento do Suíno (SMDS) é uma doença emergente e mundialmente distribuída, que tem trazido sérios prejuízos econômicos para a indústria suinícola. O Circovírus Suíno tipo 2 (PCV2), agente causal da doença, provoca lesões principalmente nos tecidos linfóides, e sugere-se que produza imunossupressão, predispondo o hospedeiro a infecções virais, bacterianas e fúngicas secundárias. Neste trabalho, é descrito um estudo da prevalência e bacteriologia das otites purulentas em suínos apresentando a SMDS, bem como em animais de baixo desenvolvimento e de crescimento normal. No total, foram examinados 385 suínos com idades entre 60 e 130 dias. De 242 animais com a SMDS, 57 (23,5%) apresentaram lesões purulentas no ouvido médio. Dentre 119 animais de baixo desenvolvimento, apenas 1 (0,7%) apresentou a lesão. Não foram detectadas lesões macroscópicas no ouvido médio dos 24 animais com crescimento normal (controles). Os agentes isolados com maior freqüência das lesões foram Arcanobacterium pyogenes, Streptococcus α– hemolíticos e Pasteurella multocida, encontrados em, respectivamente, 37 (43%), 32 (37,2%) e 24 (27,9%) dos 86 ouvidos submetidos à bacteriologia. A alta prevalência de lesões purulentas no ouvido médio de animais com a SMDS sugere que a infecção pelo PCV2 pode tornar o suíno mais suscetível às otites bacterianas. Por outro lado, a prevalência reduzida das lesões em suínos de baixo desenvolvimento sugere que a otite não representa uma causa importante de mau desempenho em suínos nas fases de crescimento e terminação. O isolamento do A. pyogenes, de Streptococcus α- hemolíticos e da P. multocida na maioria das lesões está de acordo com relatos anteriores, confirmando a importância desses organismos como agentes causais da otite média em suínos. / Postweaning Multisystemic Wasting Syndrome (PMWS) is an emerging disease disseminated globally that causes severe losses to the pig industry. Porcine circovirus type 2 (PCV2) is the causal agent of the disease and causes lesions mainly in lymphoid tissue and it is suggested that it can cause immunosuppression, predisposing the host to viral, bacterial and mycotic infections. In the present work we describe a study on prevalence and bacteriology of purulent otitis in pigs with PMWS, as well as in pigs with attrition and pigs with normal growth. A total amount of 385 animals were examined, with ages ranging from 60 to 130 days. Among 242 pigs with PMWS, 57 (23,5%) showed purulent lesions in the middle ear. Among 119 pigs with attrition, only 1 (0,7%) presented the lesion. In 24 control pigs, middle ear lesions were not detected. The agents most frequently isolated from the lesions were Arcanobacterium pyogenes, α–hemolytic Streptococci and Pasteurella multocida, found respectively in 36 (43%), 32 (37,2%) and 24 (27,9%) of 86 ears bacteriologically examined. The high prevalence of purulent lesions found in middle ear of PMWS affected pigs suggests that PCV2 infection can increase susceptibility of swine to bacterial otitis. On the other hand, the small prevalence of lesions in piglets with attrition suggests that otitis does not represent a significant cause for depressed growth in pigs from growing and finishing ages. The isolation of A. pyogenes, α-hemolytic Streptococci and P. multocida from most lesions agrees with previous reports, confirming the importance of these organisms as causal agents in the etiology of otitis media in pigs.

Porcine circovirus type 2 (PCV2) is the primary causative agent of postweaning multisystemic wasting syndrome (PMWS), whereas the ubiquitous porcine circovirus type 1 (PCV1) is nonpathogenic for pigs. Since its initial detection in a Canadian commercial swine herd in 1991, PMWS has been detected in all swine producing regions of the world and is now a serious economic problem to the swine industry. The objectives of this dissertation were to biologically, genetically and experimentally characterize both PCV1 and PCV2, to identify the genetic determinant(s) for virulence and replication, and to develop an effective genetically-engineered vaccine against PCV2 infection and PMWS. The genetic heterogeneity of PCV2 and PCV1 isolates from different geographic origins were determined. We found that, although PCV1 and PCV2 genomes were very conserved, some minor genomic variation exists among PCV1 isolates and PCV2 isolates. The nonpathogenic PCV1 and pathogenic PCV2 share only about 76% nucleotide sequence identity but have similar genomic organization. The highest sequence variability among PCV isolates is found in the immunogenic ORF2 capsid gene. Based on the sequence data in this dissertation, a universal polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was developed that is capable of detecting all known PCV isolates and differentiating between infections by nonpathogenic PCV1 and pathogenic PCV2. In order to study the structural and functional relationship of PCV genes and to develop a genetically-engineered vaccine, we constructed infectious DNA clones of both PCV1 and PCV2. By using the PCV2 infectious clone, we showed that pigs can be infected by direct intrahepatic injection of PCV2 infectious DNA clone. The pathological lesions and clinical disease associated with PCV2 infection were more definitively characterized by using the infectious DNA clone. We found that PCV2 is the primary but not the sole causative agent of PMWS, as the full spectrum of clinical PMWS was not reproduced by the infectious PCV2 DNA clone although pathological lesions characteristic of PMWS were reproduced. A chimeric vaccine was constructed by cloning the immunogenic capsid gene of the pathogenic PCV2 into the genomic backbone of the non-pathogenic PCV1 virus. We showed that the resulting chimeric PCV1-2 vaccine virus, retained the non-pathogenic nature of PCV1 but induced a protective immune response against a wild-type PCV2 challenge. In vaccinated pigs, the chimeric PCV1-2 vaccine reduced PCV2 viremia length and serum virus loads and reduced pathological lesions such as lymphoid depletion (LD) and histiocytic replacement (HR) in lymphoid tissues, inflammation and discoloration of the lymph nodes. The amounts of PCV2 antigen and PCV2 genomic copy loads in lymph node tissues were also significantly reduced. Our results indicated that the attenuated chimeric PCV1-2 virus induces protective immunity against PCV2 infection and thus could serve as an effective vaccine against PCV2 and PMWS. To improve the safety of the vaccine, we attempted to identify the genetic determinant(s) for PCV2 virulence. An isolate of PCV2 was serially passaged for 120 times in PK-15 cells. After 120 passages, a total of two amino acid mutations were identified in the capsid protein of the passage 120 virus (VP120), P110A and R191S. Compared to other known PCV1 and PCV2 sequences, the two amino acid mutations in PCV2 VP120 are unique. The VP120 virus was biologically characterized in vitro and experimentally characterized in specific-pathogen-free (SPF) pigs. The two amino acid mutations resulted in an enhanced replication ability of PCV2 VP120 in PK-15 cells and an attenuated phenotype in infected pigs. The P110A and R191S mutations in the capsid protein either alone or collectively are likely important for PCV2 virulence and replication. In summary, we genetically characterized PCV2 isolates from different geographic regions and developed a PCR-RFLP assay. We constructed and characterized infectious DNA clones of PCV1 and PCV2, and developed a genetically engineered vaccine against PCV2 infection. We also identified the genetic determinants for PCV2 virulence and replication. The vaccine developed in this study, when it becomes available, will help the swine industry control this important pathogen. / Ph. D.

Yes / The aryl hydrocarbon receptor (AHR) mediates the toxic effects of dioxin (2, 3, 7, 8-tetrachlorodibenzo-p-dioxin; TCDD), which includes thymic atrophy, steatohepatitis, and a lethal wasting syndrome in laboratory rodents. Although the mechanisms of dioxin toxicity remain unknown, AHR signaling in hepatocytes is necessary for dioxin-induced liver toxicity. We previously reported that loss of TCDD-inducible poly(adenosine diphosphate [ADP]-ribose) polymerase (TIPARP/PARP7/ARTD14), an AHR target gene and mono-ADP-ribosyltransferase, increases the sensitivity of mice to dioxin-induced toxicities. To test the hypothesis that TIPARP is a negative regulator of AHR signaling in hepatocytes, we generated Tiparpfl/fl mice in which exon 3 of Tiparp is flanked by loxP sites, followed by Cre-lox technology to create hepatocyte-specific (Tiparpfl/flCreAlb) and whole-body (Tiparpfl/flCreCMV; TiparpEx3−/−) Tiparp null mice. Tiparpfl/flCreAlb and TiparpEx3−/− mice given a single injection of 10 μg/kg dioxin did not survive beyond days 7 and 9, respectively, while all Tiparp+/+ mice survived the 30-day treatment. Dioxin-exposed Tiparpfl/flCreAlb and TiparpEx3−/− mice had increased steatohepatitis and hepatotoxicity as indicated by greater staining of neutral lipids and serum alanine aminotransferase activity than similarly treated wild-type mice. Tiparpfl/flCreAlb and TiparpEx3−/− mice exhibited augmented AHR signaling, denoted by increased dioxin-induced gene expression. Metabolomic studies revealed alterations in lipid and amino acid metabolism in liver extracts from Tiparpfl/flCreAlb mice compared with wild-type mice. Taken together, these data illustrate that TIPARP is an important negative regulator of AHR activity, and that its specific loss in hepatocytes is sufficient to increase sensitivity to dioxin-induced steatohepatitis and lethality. / This work was supported by Canadian Institutes of Health Research (CIHR) operating grants (MOP-494265 and MOP-125919), CIHR New Investigator Award, an Early Researcher Award from the Ontario Ministry of Innovation (ER10-07-028), an unrestricted research grant from the DOW Chemical Company, the Johan Throne Holst Foundation, Novo Nordic Foundation and the Norwegian Cancer Society to J.M.

This thesis explores the experience of living with cancer-related cachexia (CRC) from the patient perspective. Critique of the literature indicates few examples where patients have had the opportunity to speak. Following a challenging recruitment process, six people living with the syndrome were interviewed to elicit their narrative. Their stories were examined and themes identified relating to their personal feelings and how these affected social interactions. Thematic analysis was applied to produce what is a rich qualitative description of the experience from this small sample. Living with CRC requires development of strategies to survive. Emergent themes included the loss of sense of self and a changing relationship to the social world, social isolation and dissatisfaction with truth-telling by health professionals. Recommendations are made to mitigate the suffering of patients by empowering them through better information and acknowledgement of their condition. The balance between nutrition and wellbeing is re-examined, calling for a reorientation of perspective from a focus on intake towards a focus on quality of life. This clearly falls within the nurse-as patient-advocate paradigm and the relevance and meaning of this research to the nursing profession is explored. Potential areas for further research in regards to both patient experience and nursing practice are extrapolated.